CLINICAL RECOMMENDATIONS |
Alekseeva L.I., Lila A.M., Taskina E.A., Mazurov V.I., Martynov A.I., Barantsevich E.R., Vasylkin A.K., Gaydukova I.Z., Karateev A.E., Kashevarova N.G., Kochish A.Yu., Strebkova E.A., Trofimov E.A., Chichasova N.V., Shostak N.A.
Clinical guidelines (project) for the diagnostics and treatment of primary osteoarthritis for primary care specialists (general practitioners, therapists)
|
7-22 |
ORIGINAL STUDIES |
Mazurov V.I., Melnikov E.S., Morozova K.P., Evgrafova V.E.
Peculiarities of the course of rheumatoid arthritis in patients with thrombocytosis and comorbid conditions
|
23-28 |
Samigullina R.R., Vasilenko E.A., Mazurov V.I.
Influence of comorbid pathology at the course of spondyloarthritis in patients receiving genetically engineered biological therapy
|
29-36 |
Trofimov E.A., Mazurov V.I., Bashkinov R.A., Trofimova A.S., Gaydukova I.Z.
Comparative analysis of efficacy and safety of different medicines containing celecoxib in patients with knee osteoarthritis
|
37-47 |
Kovalev A.V., Tishko V.V., Polyakov A.S., Gornostaev D.A., Zhivopisceva A.M., Bologov S.G., Tyrenko V.V.
The effect of aerobic exercise on the development of iron deficiency in young women
|
48-54 |
Bratilova E.S., Kachnov V.A., Tyrenko V.V., Afonaskov O.V.
Predictors of cardiovascular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults
|
55-62 |
Kravchenko A.Ya., Budnevsky A.V., Chernik T.A., Tokmachev R.E.
Soluble suppression of tumorigenicity 2 (sST2) as a predictor of adverse outcomes of chronic heart failure
|
63-69 |
Roytberg G.E., Slastnikova I.D., Sharkhun O.O., Davydova A.S.
Value of cardiovascular risk factors in pre-test assessment of coronary heart disease
|
70-77 |
REVIEWS |
Meshkov A.D., Maslyansky A.L., Tkacheva O.N., Mazurov V.I.
Treatment of giant cell arteritis: current possibilities and prospects of steroid-sparing therapy
|
78-88 |
GUIDELINES FOR PRACTITIONERS |
Gaydukova I.Z., Skvortsova T.E., Vorobyev S.L.
Adjuvant-associated systemic lupus erythematosus with urticarial vasculitis and sarcoid-like granulomas formation
|
89-99 |
LECTURES & REPORTS |
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy
|
100-106 |
Guideline for practitioners |
Mazurov V.I., Trofimov E.A., Gaidukova I.Z., Trofimova A.S.
Still’s disease in adults: Methodological recommendations for general practitioners, therapists
|
108-115 |
Bolieva L.Z., Bolotina L.V., Galstyan G.R., Drapkina O.M., Ekusheva E.V., Kaprin A.D., Lukina E.A., Malyavin A.G., Martynov A.I., Ponomarev R.V., Suponeva N.A., Tarasova L.V.
Resolution of the Expert Council «Vitamin B12 deficiency in clinical practice»
|
116-121 |
Gazdanova A.A., Plieva A.S.
The significance of examination of the skin and its appendages in the rheumatic diseases diagnosis
|
122-131 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Mazurov V.I., Bashkinov R.A., Inamova O.V., Petrova M.S., Morozova K.P.
Therapy of osteoarthritis in combination with asymptomatic hyperuricemia: results of a pilot study
|
132-144 |
Zakharov V.V., Ostroumova O.D., Kochetkov A.I., Klepikova M.V., Fedin A.I.
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension
|
145-159 |
Kudina E.V. Samkova I.A.
Anti-inflammatory therapy of joint syndrome in an outpatient practitioner
|
160-168 |
Activities of RNMOT |
7th day of the European Federation of Internal Medicine (EFIM)
|
169 |
36th World Congress of Internal Medicine
|
170-171 |
Congress of therapists of the Northwestern Federal District «Dialogues on internal medicine»
|
172-173 |
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (January - February 2023)
|
174-176 |
JUBILEE |
Konstantin Aleksandrovich SHEMEROVSKY is 75
|
177-179 |